Skip to main content
. 2008 Sep 12;415(Pt 1):135–144. doi: 10.1042/BJ20080435

Table 3. Substrate specificity of TbEK1 (formerly TbC/EK1) and TbC/EK2 to utilize analogues modified by extra substitutents on the carbon backbone of the acceptor substrate.

Results are means±S.D. (n≥3).graphic file with name bic030i009.jpg

R1 R2 R3 Compound TbEK1 relative rate* TbC/EK2 relative rate
-N+(CH3) 3 -H -H Choline 0.03±1.59 100.00±7.97
-NH2 -H -H Ethanolamine 100.00±1.65 33.34±3.34
-NH2 -CH3 -H R(−)-2-Aminopropan-1-ol 107.91±2.77 109.94±15.42
-NH2 -CH3 -H S(+)-2-Aminopropan-1-ol 93.75±4.02 22.38±1.87
-NH2 -(CH3)2 -H 2-Amino-2-methylpropan-1-ol 25.58±3.98 46.41±6.57
-NH2 -CH2CH3 -H S(+)-2-Aminobutan-1-ol 114.07±5.84 40.72±4.93
-NH2 -CH2CH3 -H R(−)-2-Aminobutan-1-ol 101.74±5.76 130.40±9.10
-NH2 -COOH -H L-Serine 0.94±2.25 0.00±0.00
-NH2 -H -CH3 R(−)-1-Aminopropan-2-ol 52.41±4.50 7.16±0.60
-NH2 -H -CH3 S(+)-1-Aminopropan-2-ol 6.07±2.13 1.37±0.15
-CH2NH2 -H -H 3-Aminopropan-1-ol 37.52±2.96 44.52±4.33
(CH2)2NH2 -H -H 4-Aminobutan-1-ol 0.05±1.93 59.95±6.00

*Analogues are compared with ethanolamine at the constant concentration of 1 mM and a saturating concentration of ATP to give a relative rate (ethanolamine=100).

†Analogues are compared with choline at the constant concentration of 1 mM and a saturating concentration of ATP to give a relative rate (choline=100).